EE357 Cost per Responder Analysis Comparing Adagrasib and Sotorasib in Patients With KRAS G12C-Mutated Previously Treated Non-Small Cell Lung Cancer (NSCLC)
Dec 1, 2023, 00:00 AM
10.1016/j.jval.2023.09.623
https://www.valueinhealthjournal.com/article/S1098-3015(23)03753-1/fulltext
Section Title :
Section Order :
10109
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)03753-1&doi=10.1016/j.jval.2023.09.623